Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Ectopic Neuroligin Signaling in Pediatric Glioblastoma |
University of Utah / Alex Shcheglovitov, PhD |
Innovation Grants |
2023 |
Utah |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells |
Baylor College of Medicine / Jason Shohet, MD, PhD |
Innovation Grants |
2011 |
Texas |
Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression |
University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD |
'A' Award Grants |
2016 |
Texas |
Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model |
University of Texas Southwestern Medical Center / Kathleen Galindo |
Young Investigator Grants |
2012 |
Texas |
Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma |
University of Texas Southwestern Medical Center / Genevieve Kendall, PhD |
Young Investigator Grants |
2015 |
Texas |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |